Navidea Biopharmaceuticals Stock Filter Stocks by Fundamentals
| NAVB Stock | USD 0.0001 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Navidea Biopharmaceutica's long-term financial health and intrinsic value.
Navidea |
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
Navidea Fundamentals
| Return On Equity | -11.0 | |||
| Return On Asset | -1.22 | |||
| Current Valuation | 3.5 M | |||
| Shares Outstanding | 100.08 M | |||
| Shares Owned By Insiders | 35.43 % | |||
| Shares Owned By Institutions | 1.50 % | |||
| Number Of Shares Shorted | 2.69 M | |||
| Price To Earning | 0.53 X | |||
| Price To Book | 8.16 X | |||
| Price To Sales | 84.14 X | |||
| Revenue | 65.65 K | |||
| Gross Profit | (119.3 K) | |||
| EBITDA | (14.05 M) | |||
| Net Income | (15.18 M) | |||
| Cash And Equivalents | 328.01 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 2.43 M | |||
| Debt To Equity | 1.20 % | |||
| Current Ratio | 0.22 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (8.99 M) | |||
| Short Ratio | 0.52 X | |||
| Earnings Per Share | (0.39) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 11 | |||
| Beta | 1.5 | |||
| Market Capitalization | 8.04 M | |||
| Total Asset | 4.37 M | |||
| Retained Earnings | (388 M) | |||
| Working Capital | (6.74 M) | |||
| Current Asset | 12.58 M | |||
| Current Liabilities | 6.18 M | |||
| Net Asset | 4.37 M |
About Navidea Biopharmaceutica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Navidea Biopharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Navidea Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Navidea Biopharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Navidea Pink Sheet
Navidea Biopharmaceutica financial ratios help investors to determine whether Navidea Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Navidea with respect to the benefits of owning Navidea Biopharmaceutica security.